A systematic review of intracranial chondrosarcoma and survival.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMC 3795514)

Published in J Clin Neurosci on September 30, 2009

Authors

Orin G Bloch1, Brian J Jian, Isaac Yang, Seunggu J Han, Derick Aranda, Brian J Ahn, Andrew T Parsa

Author Affiliations

1: Department of Neurological Surgery, University of California at San Francisco, 505 Parnassus Avenue, San Francisco, California 94143, USA.

Articles citing this

Pituitary Chondrosarcoma presenting as a sellar and suprasellar mass with parasellar extension: An Unusual presentation. Iran J Pathol (2016) 0.84

Mesenchymal chondrosarcoma of bone and soft tissue: a systematic review of 107 patients in the past 20 years. PLoS One (2015) 0.82

Intraoperative high-field magnetic resonance imaging combined with neuronavigation-guided resection of intracranial mesenchymal chondrosarcoma in Broca's area: a rare case report and literature review. Int J Clin Exp Med (2015) 0.82

Diagnosis and microsurgical treatment of chondromas and chondrosarcomas of the cranial base. Oncol Lett (2014) 0.77

Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute. Neuro Oncol (2015) 0.76

Classical intracranial chondrosarcoma: A case report. Oncol Lett (2016) 0.75

Comparing operative exposures of the le fort I osteotomy and the expanded endoscopic endonasal approach to the clivus. J Neurol Surg B Skull Base (2014) 0.75

Primary Bone Tumors of the Skull: Spectrum of 125 Cases, with Review of Literature. J Neurol Surg B Skull Base (2016) 0.75

Parasellar Chondrosarcoma in Three Young Patients: A Diagnosis of Caution. J Neurosci Rural Pract (2017) 0.75

Skull Base Tumors and Tumor-Like Lesions: A Pictorial Review. Pol J Radiol (2017) 0.75

Skull base bony lesions: Management nuances; a retrospective analysis from a Tertiary Care Centre. Asian J Neurosurg (2017) 0.75

Articles cited by this

(truncated to the top 100)

Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer (1977) 4.07

Proton radiation therapy for chordomas and chondrosarcomas of the skull base. J Neurosurg (1999) 2.18

Cranial chordomas in children and adolescents. J Neurosurg (1996) 1.90

Chordomas and chondrosarcomas of the cranial base: results and follow-up of 60 patients. Neurosurgery (1995) 1.80

The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol (2005) 1.77

Subtemporal-preauricular infratemporal fossa approach to large lateral and posterior cranial base neoplasms. J Neurosurg (1987) 1.69

National cancer database report on chondrosarcoma of the head and neck. Head Neck (2000) 1.69

Chondrosarcoma of the mobile spine: report on 22 cases. Spine (Phila Pa 1976) (2000) 1.67

Chondrosarcomas of the head and neck. World J Surg (1993) 1.65

Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. Arch Pathol Lab Med (1993) 1.61

Intracranial extraskeletal myxoid chondrosarcoma: case report and review of the literature. Acta Neurochir (Wien) (2002) 1.60

Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg (1993) 1.55

Operative management of tumors involving the cavernous sinus. J Neurosurg (1986) 1.53

Definitive radiation therapy for chordoma and chondrosarcoma of base of skull and cervical spine. J Neurosurg (1982) 1.44

Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys (2006) 1.33

Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol (1999) 1.32

Chordoma and chondrosarcoma of the cranial base: an 8-year experience. Neurosurgery (1989) 1.28

The endoscopic transnasal transsphenoidal approach for the treatment of cranial base chordomas and chondrosarcomas. Neurosurgery (2006) 1.28

Lesions of the petrous apex: diagnosis and management. Otolaryngol Clin North Am (2007) 1.26

Primary chondrosarcoma of the head and neck in pediatric patients: a clinicopathologic study of 14 cases with a review of the literature. Cancer (2000) 1.19

Intracranial chondrosarcoma: review of the literature and report of 15 cases. J Neurol Neurosurg Psychiatry (1998) 1.13

Chordoma and chondroid neoplasms of the spheno-occiput. An immunohistochemical study of 41 cases with prognostic and nosologic implications. Cancer (1993) 1.10

Chondrosarcoma of the head and neck. Laryngoscope (1984) 1.07

Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull. J Neurosurg (1989) 1.05

The role of radiosurgery in the management of chordoma and chondrosarcoma of the cranial base. Neurosurgery (1991) 1.04

Primary non-skeletal intracranial cartilaginous neoplasms: report of a chondroma and a mesenchymal chondrosarcoma. J Neurol Neurosurg Psychiatry (1970) 1.04

A combined infratemporal and posterior fossa approach for the removal of giant glomus tumors and chondrosarcomas. Surg Neurol (1987) 1.02

Chondroma/Chondrosarcoma of the spine. Neurosurg Clin N Am (2008) 1.01

Endoscopic treatment of the isolated sphenoid sinus lesions. Eur Arch Otorhinolaryngol (2004) 1.01

Particle beam radiotherapy for head and neck tumors: radiobiological basis and clinical experience. Head Neck (2006) 1.00

Trauma to the corpus callosum: MR features. AJNR Am J Neuroradiol (1989) 1.00

Probable causes of recurrence in patients with chordoma and chondrosarcoma of the base of skull and cervical spine. Int J Radiat Oncol Biol Phys (1993) 1.00

Stereotactic fractionated radiotherapy for chordomas and chondrosarcomas of the skull base. Int J Radiat Oncol Biol Phys (2000) 0.99

Chondrosarcoma of the skull base. Laryngoscope (2002) 0.97

Cranial chondrosarcomas. Report of four cases and review of the literature. Radiology (1977) 0.96

Cranial and intracranial cartilaginous tumours. Clin Radiol (1968) 0.96

Extraskeletal myxoid chondrosarcoma of the falx. Neurosurgery (1992) 0.95

Chordomas of the skull base: follow-up review and prognostic factors. Neurosurg Focus (2001) 0.95

Remitting sixth nerve palsy in skull base tumors. Arch Ophthalmol (1993) 0.94

The subtemporal-transpetrous approach for excision of petroclival tumors. Am J Otol (1996) 0.94

Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases. Am J Surg Pathol (1992) 0.94

The role of stereotactic radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys (1997) 0.93

Radiation-induced tumors of the central nervous system occurring in childhood and adolescence. Four unusual lesions in three patients and a review of the literature. Childs Nerv Syst (2000) 0.93

Cartilaginous tumors of the base of skull. Am J Roentgenol Radium Ther Nucl Med (1969) 0.92

Primary intracranial myxoid chondrosarcoma: report of a case and review of the literature. J Korean Med Sci (2003) 0.91

Chondrosarcoma of the skull base. Otolaryngol Head Neck Surg (1986) 0.91

Chondrosarcoma of the head and neck. Am J Surg (1970) 0.90

Chondrosarcomas of the skull base: review of the literature and report of two cases. J Craniomaxillofac Surg (1997) 0.90

Chondrosarcoma of the temporal bone. Diagnosis and treatment of 13 cases and review of the literature. Cancer (1986) 0.89

Mesenchymal tumors of the skull base with particular reference to surgical management and outcome. Skull Base Surg (1992) 0.89

Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma. J Clin Endocrinol Metab (2001) 0.88

Intracranial malignant cartilaginous tumours. Report of two cases and review of literature. Acta Neurochir (Wien) (1978) 0.87

Skull base chondrosarcoma originating from the petroclival junction. Otol Neurotol (2005) 0.87

The transsphenoethmoid approach to the sphenoid sinus and clivus. Neurosurgery (1992) 0.87

Management of intracavernous tumours: an 11-year experience. Acta Neurochir Suppl (Wien) (1991) 0.86

Management of cranial base chondrosarcomas. Neurosurgery (2006) 0.86

A multidisciplinary team approach to skull base chondrosarcomas. J Neurosurg (2001) 0.86

Intracranial mesenchymal chondrosarcoma. AJNR Am J Neuroradiol (1988) 0.85

Intracranial chondrosarcoma with extracranial metastases. Case report. J Neurosurg (1972) 0.85

Mesenchymal chondrosarcoma of the sellar region. Acta Neurochir (Wien) (2003) 0.85

Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters? J Neurosurg (2008) 0.85

Conventional and perfusion MR imaging of parafalcine chondrosarcoma. AJNR Am J Neuroradiol (2003) 0.84

Presentation and management of uncommon lesions of the middle ear. Am J Otol (1995) 0.84

Primary cranial and intracranial chondrosarcoma. A survey. Acta Neurochir (Wien) (1985) 0.84

Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chondrosarcomas. Neurosurgery (2006) 0.83

Cranial base chordomas. Clin Neurosurg (1997) 0.83

Chondrosarcoma of the skull base: a series of eight cases. Neurosurgery (1993) 0.83

Synthesizing medical evidence: systematic reviews and metaanalyses. Neurosurg Focus (2005) 0.81

Intracranial extraskeletal mesenchymal chondrosarcoma: case report. Neurosurgery (2000) 0.81

Parasellar chondrosarcoma--case report. Neurol Med Chir (Tokyo) (1986) 0.81

Supratentorial cartilaginous tumors. (A report of 2 cases). Dis Nerv Syst (1974) 0.80

Intracranial chondrosarcoma--case report. Neurol Med Chir (Tokyo) (1990) 0.80

Myxoid tumours in the temporal bone. J Laryngol Otol (1989) 0.80

Extracranial skull base chondrosarcoma. Ear Nose Throat J (1989) 0.80

Case report 476: Chondrosarcoma of base of skull (CBS). Skeletal Radiol (1988) 0.80

Unusual presentation of petro-clival chondrosarcoma: short report. J Clin Neurosci (2004) 0.80

Chondrosarcoma of the jugular foramen. Am J Otol (1994) 0.80

Recurrent chondrosarcoma of the cranial base: a durable response to ifosfamide-doxorubicin chemotherapy. J Neurooncol (1999) 0.79

Primary intracranial chondrosarcoma: a report of two cases. Neurosurgery (1985) 0.79

Intracranial chondrosarcoma: a case report and review of the literature. J Neurooncol (2004) 0.79

Mesenchymal chondrosarcoma of the craniocervical junction. Clin Neurol Neurosurg (1990) 0.79

Falcine chondrosarcoma: case report and literature review. Neurosurgery (1985) 0.79

Cavernous sinus exenteration for invasive cranial base tumors. Neurosurgery (2003) 0.78

Intracranial mesenchymal chondrosarcoma in an infant. Med Pediatr Oncol (2000) 0.78

Chondrosarcoma of the posterior fossa--case report. Neurol Med Chir (Tokyo) (1989) 0.78

BNCT for recurrent intracranial meningeal tumours - case reports. Acta Neurol Scand (2007) 0.78

Chondrosarcoma of the temporal bone in an infant: case report and review of the literature. Neurosurgery (1992) 0.78

Successful chemoradiation therapy for high-grade skull base chondrosarcoma in a child. Childs Nerv Syst (1995) 0.78

Skull base dumbbell tumor: surgical experience with two adolescents. Ann Otol Rhinol Laryngol (1992) 0.78

Chondrosarcoma of the skull base: long-term follow-up. Otol Neurotol (2006) 0.78

Intracranial mesenchymal chondrosarcoma. Acta Neuropathol (1973) 0.78

View from beneath--pathology in focus. Primary intracranial mesenchymal chondrosarcoma. J Laryngol Otol (1989) 0.78

Intracranial chondrosarcoma. Acta Neurochir (Wien) (1997) 0.77

Radiation-induced intracranial fibrochondrosarcoma. J Neurol (1986) 0.77

Chondrosarcoma of the petrous apex. Dilemmas in diagnosis and treatment. J Laryngol Otol (1997) 0.77

A radiosensitive chondrosarcoma of the sphenoid sinus and base of the skull. Report of a case. Laryngoscope (1972) 0.77

Chondrosarcoma in the optic canal--a case report with ultrastructural study. Neurol Med Chir (Tokyo) (1985) 0.77

Radiation-induced cerebellar chondrosarcoma. Case report. J Neurosurg (1984) 0.77

Combined transpetrosal-subtemporal craniotomy for clival tumors with extension into the posterior fossa. Laryngoscope (1995) 0.77

Intracranial mesenchymal chondrosarcoma with osteoid formation: report of a pediatric case. Childs Nerv Syst (2003) 0.77

Articles by these authors

An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg (2011) 6.32

Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol (2008) 2.71

Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg (2010) 2.42

Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg (2010) 2.19

Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg (2013) 2.16

Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15

Complications of lumboperitoneal shunts. Neurosurgery (2007) 2.07

Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol (2012) 2.04

Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res (2013) 1.86

Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg (2010) 1.74

Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg (2010) 1.72

The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg (2010) 1.67

Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg (2010) 1.67

Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg (2011) 1.67

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg (2008) 1.66

Cancer and the complement cascade. Mol Cancer Res (2010) 1.64

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg (2012) 1.64

The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci (2009) 1.62

Beyond audiofacial morbidity after vestibular schwannoma surgery. J Neurosurg (2009) 1.59

Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr (2012) 1.57

Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss. J Neurosurg (2010) 1.55

Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg (2013) 1.55

Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg (2011) 1.54

Extent of resection and the long-term durability of vestibular schwannoma surgery. J Neurosurg (2011) 1.53

Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article. J Neurosurg (2010) 1.53

Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res (2006) 1.52

Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review. J Neurosurg Spine (2013) 1.51

Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg (2015) 1.48

Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma. J Neurosurg (2010) 1.48

Gliomas: advances in molecular analysis and characterization. Surg Neurol (2005) 1.46

A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg (2010) 1.46

What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg (2014) 1.44

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol (2009) 1.43

Complications and perioperative factors associated with learning the technique of minimally invasive transforaminal lumbar interbody fusion (TLIF). J Clin Neurosci (2011) 1.41

Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg (2010) 1.38

Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol (2012) 1.38

Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer (2011) 1.35

Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J Immunother (2009) 1.33

The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus (2011) 1.33

Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. J Neurosurg (2009) 1.32

Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg (2010) 1.28

Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology (2010) 1.28

CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci (2010) 1.26

Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol (2009) 1.25

Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg (2005) 1.25

Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol (2013) 1.25

Changes in transcranial motor evoked potentials during intramedullary spinal cord tumor resection correlate with postoperative motor function. Neurosurgery (2005) 1.24

Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein. Clin Cancer Res (2012) 1.15

The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res (2010) 1.14

Temozolomide and other potential agents for the treatment of glioblastoma multiforme. Neurosurg Clin N Am (2012) 1.13

Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery (2012) 1.13

Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease. J Neurosurg Spine (2012) 1.11

A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg (2010) 1.11

Extent of surgical resection predicts seizure freedom in low-grade temporal lobe brain tumors. Neurosurgery (2012) 1.10

Medicinal herb use among asthmatic patients attending a specialty care facility in Trinidad. BMC Complement Altern Med (2005) 1.09

A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg (2010) 1.07

Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. PLoS One (2012) 1.07

Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol (2009) 1.06

Cranial chondrosarcoma and recurrence. Skull Base (2010) 1.06

Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus (2010) 1.05

Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy. Neurosurg Clin N Am (2010) 1.04

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol (2014) 1.04

Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer (2010) 1.03

Embolization of skull base meningiomas and feeding vessels arising from the internal carotid circulation. Neurosurgery (2011) 1.03